Oxalic Acid

Oxalic Acid

SCHEMBL1405809

CC(C)n1nc(C(=O)NCC2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)c2ccccc21.O=C(O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 20/20 1.00
HTR2A P28223 9/20 1.00
KCNH2 Q12809 4/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1405907 0.98 HTR4 (1.00) HTR4HTR2AKCNH2
SCHEMBL13220645 0.89 HTR4 (1.00) HTR4HTR2AKCNH2
Hydrochloric Acid SCHEMBL7341669 0.89 HTR4 (1.00) HTR4HTR2AKCNH2
SCHEMBL3042859 0.87 HTR4 (1.00) HTR4HTR2AKCNH2
Hydrochloric Acid SCHEMBL4413286 0.86 HTR4 (1.00) HTR4HTR2AKCNH2
SCHEMBL1405951 0.86 HTR4 (0.98) HTR4HTR2AKCNH2
Hydrochloric Acid SCHEMBL1405944 0.85 HTR4 (1.00) HTR4HTR2AKCNH2
Oxalic Acid SCHEMBL7344927 0.85 HTR4 (0.85) HTR4HTR2AKCNH2
SCHEMBL1379554 0.83 HTR4 (0.75) HTR4HTR2AKCNH2
SCHEMBL3032068 0.82 HTR4 (0.81) HTR4HTR2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1622892-B1 INDAZOLES HAVING ANALGESIC ACTIVITY ACRAF (IT) 2011-03-09 EP claimed
US-7662836-B2 Indazole having analgesic activity AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2010-02-16 US claimed
US-20070010555-A1 Indazole having analgesic activity AZIENDE CHIM. RUIN. ANGEL. FRA. A.C.R.A.F. S.P.A. (IT) 2007-01-11 US claimed
EP-1622892-A1 INDAZOLES HAVING ANALGESIC ACTIVITY AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) 2006-02-08 EP claimed
WO-2004101548-A1 INDAZOLE HAVING ANALGESIC ACTIVITY , AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2004-11-25 WO claimed
US-8415476-B2 Indazole having analgesic activity AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2013-04-09 US disclosed
EP-1622892-B1 INDAZOLES HAVING ANALGESIC ACTIVITY ACRAF (IT) 2011-03-09 EP disclosed
US-20100094015-A1 INDAZOLE HAVING ANALGESIC ACTIVITY AZIENDE CHIM. RIUN. ANGEL. FRA. A.C.R.A.F. S.P.A. (IT) 2010-04-15 US disclosed
US-7662836-B2 Indazole having analgesic activity AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2010-02-16 US disclosed
US-20070010555-A1 Indazole having analgesic activity AZIENDE CHIM. RUIN. ANGEL. FRA. A.C.R.A.F. S.P.A. (IT) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094015-A1 INDAZOLE HAVING ANALGESIC ACTIVITY OPRK1, OPRD1, ACHE HTR4 717/4885HTR2A 358/4885KCNH2 616/4885
US-20070010555-A1 Indazole having analgesic activity ACHE, CYP3A43, RPL35A HTR4 2033/4885HTR2A 2495/4885KCNH2 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.